References
- Ray JG, O’Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med. 2001;94(8):435–444.
- Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779.
- HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynecol Obstet. 2002;78(1):69–77.
- al-Okail MS, al-Attas OS. Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients. Endocr J. 1994;41(4):355–360.
- Daskalakis G, Marinopoulos S, Krielesi V, et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand. 2008;87(4):403–407.
- Kovo M, Granot Y, Schreiber L, et al. Pregnancy outcome and placental pathology differences in term gestational diabetes with and without hypertensive disorders. J Matern Fetal Neonatal Med. 2016;29(9):1462–1467.
- Han CS, Herrin MA, Pitruzzello MC, et al. Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiency. Am J Reprod Immunol. 2015;73(4):362–371.
- Groen B, Uuldriks GA, de Vos P, et al. Impaired trophoblast invasion and increased numbers of immune cells at day 18 of pregnancy in the mesometrial triangle of type 1 diabetic rats. Placenta. 2015;36(2):142–149.
- Basak S, Das MK, Srinivas V, et al. The interplay between glucose and fatty acids on tube formation and fatty acid uptake in the first trimester trophoblast cells, HTR8/SVneo. Mol Cell Biochem. 2015;401(1–2):11–19.
- Cawyer CR, Horvat D, Leonard D, et al. Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol. 2014;211(5):541.e1–541.e8.
- Taricco E, Radaelli T, Nobile de Santis MS, et al. IFoetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003;24(4):343–347.
- Higgins M, Mc Auliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev. 2010;6(2):116–125.
- Ashfaq M, Janjua MZ, Channa MA. Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. J Ayub Med Coll Abbottabad. 2005;17(1):44–47.
- Zorn TM, Zúñiga M, Madrid E, et al. Maternal diabetes affects cell proliferation in developing rat placenta. Histol Histopathol. 2011;26(8):1049–1056.
- Acar N, Korgun ET, Cayli S, et al. IIs there a relationship between PCNA expression and diabetic placental development during pregnancy? Acta Histochem. 2008;110(5):408–417.
- Ji L, Chen Z, Xu Y, et al. Systematic characterization of autophagy in gestational diabetes mellitus. Endocrinology. 2017;158(8):2522–2532.
- Fröhlich JD, Huppertz B, Abuja PM, et al. Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia. Am J Pathol. 2012;180(1):153–164.
- Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther. 2017;178:18–30.
- Murray GI, Taylor MC, McFadyen MC, et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 1997;57(14):3026–3031.
- Chang I, Mitsui Y, Kim SK, et al. Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. Oncotarget. 2017;8(24):39087–39100.
- Kwon YJ, Baek HS, Ye DJ, et al. CYP1B1 enhances cell proliferation and metastasis through induction of EMT and activation of Wnt/beta-catenin signaling via Sp1 upregulation. PLos One. 2016;11(3):e151598.
- Shatalova EG, Klein-Szanto AJ, Devarajan K, et al. Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis. Cancer Prev Res (Phila). 2011;4(1):107–115.
- Saini S, Hirata H, Majid S, et al. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. Cancer Res. 2009;69(17):7038–7045.
- Ferretti C, Bruni L, Dangles-Marie V, et al. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update. 2007;13(2):121–141.
- Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38(8):1567–1582.
- Alfadhli EM. Gestational diabetes mellitus. Saudi Med J. 2015;36(4):399–406
- Liu X, Huang T, Li L, et al. CYP1B1 deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6J mice. Am J Transl Res. 2015;7(4):761–771.
- Yang M, Chen Y, Chen L, et al. miR-15b-AGO2 play a critical role in HTR8/SVneo invasion and in a model of angiogenesis defects related to inflammation. Placenta. 2016;41:62–73.
- Muschol-Steinmetz C, Jasmer B, Kreis NN, et al. B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells. Cell Cycle. 2016;15(6):827–839.
- Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–268.
- Chen H, Chen H, Wu Y, et al. Adiponectin exerts antiproliferative effect on human placenta via modulation of the JNK/c-Jun pathway. Int J Clin Exp Pathol. 2014;7(6):2894–2904.
- Ji L, Brkić J, Liu M, et al. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med. 2013;34(5):981–1023.
- Ishihara N, Matsuo H, Murakoshi H, et al. Changes in proliferative potential, apoptosis and Bcl-2 protein expression in cytotrophoblasts and syncytiotrophoblast in human placenta over the course of pregnancy. Endocr J. 2000;47(3):317–327.
- Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12(1):23.
- Weiss U, Cervar M, Puerstner P, et al. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia. 2001;44(2):209–219.
- Bruchova H, Vasikova A, Merkerova M, et al. Effect of maternal tobacco smoke exposure on the placental transcriptome. Placenta. 2010;31(3):186–191.
- Sindhu RK, Koo JR, Sindhu KK, et al. Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats. Free Radic Res. 2006;40(9):921–928.
- Oh SJ, Choi JM, Yun KU, et al. Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats. Chem Biol Interact. 2012;195(3):173–179.
- Liehr JG, Ricci MJ, Jefcoate CR, et al. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A. 1995;92(20):9220–9224.
- Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 2005;227(2):115–124.
- Lind AB, Wadelius M, Darj E, et al. Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol Toxicol. 2003;92(6):295–299.
- Mitsui Y, Chang I, Fukuhara S, et al. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015;15:942.
- Belkacemi L, Lash GE, Macdonald-Goodfellow SK, et al. Inhibition of human trophoblast invasiveness by high glucose concentrations. J Clin Endocrinol Metab. 2005;90(8):4846–4851.
- Wentzel PUJ, Eriksson UJ. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes. 1998;47(4):677–684.
- Peuchant E, Brun JL, Rigalleau V, et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem. 2004;37(4):293–298.
- Tang Y, Scheef EA, Wang S, et al.. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood. 2009;113(3):744–754.
- Verma S, Saxena R, Siddiqui MH, et al. Evaluation of CYP1B1 expression, oxidative stress and Phase 2 detoxification enzyme status in oral squamous cell carcinoma patients. J Clin Diagn Res. 2017;11(3):BC01–BC05.
- Thirunavukkarasu S, Khan NS, Song CY, et al. Cytochrome P450 1B1 contributes to the development of angiotensin II-induced aortic aneurysm in male Apoe(−/−) mice. Am J Pathol. 2016;186(8):2204–2219.